This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Sooty mangabey monkeys (SMs) naturally infected with SIV maintain normal levels of CD4 T lymphocytes and do not develop AIDS despite chronic high level virus replication, short longevity of infected CD4+ T cells and increased rates of CD4+ T cell turnover. Interestingly, despite otherwise intact immune function, SIV-infected SMMs manifest limited or absent anti-SIV specific cytotoxic T cell (CTL) responses. We have further shown that SIV-infected SMMs possess preserved bone marrow, thymic and peripheral lymphoid sources for T lymphocyte production, and manifest levels of immune activation and apoptosis far lower than those seen in pathogenic infections with SIV in rhesus macaques (RMs) and with HIV in humans. These data suggest that the direct consequences of high level virus replication alone cannot account for the progressive CD4+ T cell depletion leading to AIDS. Rather, SIV-infected SMs may be spared, by their failure to mount significant antiviral immune responses, much of the bystander damage seen in pathogenic primate lentivirus infections that contributes to both accelerated CD4 depletion and compromised host immune regenerative capacity. We propose to test the hypothesis that the type and magnitude of the host immune responses to virus infection determines whether or not disease occurs by (1) detailed characterization of primary SIV infection in RMs and SMs by virologic, immunologic and genetic methods, (2) induction of active cellular anti-SIV responses in acutely-infected SMs and evaluation of whether disease develops in an otherwise refractory host and (3) blockade or alteration of host cellular immune responses to SIV in acutely-infected RMs, and evaluation of whether protection from disease progression is achieved in an otherwise susceptible host.
Showing the most recent 10 out of 912 publications
